ArticleVaccines2025

SARS-CoV-2 mRNA Vaccines Induce Cross-Reactive Antibodies to NL63 Coronavirus but Do Not Boost Pre-Existing Immunity Anti-NL63 Antibody Responses.

Weiyi Tang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.